title: Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy.
authors.affiliation: Department of Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust & Brighton and Sussex Medical School, Brighton, BN2 5BE, UK, sabina.dizdarevic@bsuh.nhs.uk.
authors.forename: S
authors.initials: S
authors.lastname: Dizdarevic
authors.forename: R
authors.initials: R
authors.lastname: McCready
authors.forename: J F C
authors.initials: JF
authors.lastname: Turner
authors.forename: M C
authors.initials: MC
authors.lastname: Bagley
authors.forename: P
authors.initials: P
authors.lastname: Blower
authors.forename: P
authors.initials: P
authors.lastname: Schmid
authors.forename: G
authors.initials: G
authors.lastname: Flux
authors.forename: A
authors.initials: A
authors.lastname: Hall
authors.forename: I
authors.initials: I
authors.lastname: Ziv
mesh_terms: D017209:Apoptosis; D006801:Humans; D008764:Methylmalonic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009369:Neoplasms / Q000532:radiotherapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*
chemical_list: C532430:5-fluoropentyl-2-methylmalonic acid; D019275:Radiopharmaceuticals; D008764:Methylmalonic Acid